EMD-27706
Vaccine elicited Antibody MU89 bound to CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 Env trimer
EMD-27706
Single-particle3.57 Å
Deposition: 26/07/2022Map released: 19/04/2023
Last modified: 16/10/2024
Sample Organism:
Human immunodeficiency virus,
Mus musculus,
Homo sapiens
Sample: V3-glycan vaccine induced antibody MU89 in complex with CH848.3.D0949.10.17chim.6R.DS.SOSIP.664_N133D_N138T HIV Env trimer
Fitted models: 8dto
Deposition Authors: Stalls V, Acharya P
Sample: V3-glycan vaccine induced antibody MU89 in complex with CH848.3.D0949.10.17chim.6R.DS.SOSIP.664_N133D_N138T HIV Env trimer
Fitted models: 8dto
Deposition Authors: Stalls V, Acharya P
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction.
Wiehe K,
Saunders KO,
Stalls V,
Cain DW,
Venkatayogi S,
Martin Beem JS,
Berry M,
Evangelous T,
Henderson R,
Hora B,
Xia SM,
Jiang C,
Newman A,
Bowman C,
Lu X,
Bryan ME,
Bal J,
Sanzone A,
Chen H,
Eaton A,
Tomai MA,
Fox CB 
,
Tam YK,
Barbosa C,
Bonsignori M,
Muramatsu H,
Alam SM,
Montefiori DC,
Williams WB,
Pardi N,
Tian M,
Weissman D,
Alt FW,
Acharya P,
Haynes BF
(2024) Cell Host Microbe , 32 , 693 - 709.e7
,
Tam YK,
Barbosa C,
Bonsignori M,
Muramatsu H,
Alam SM,
Montefiori DC,
Williams WB,
Pardi N,
Tian M,
Weissman D,
Alt FW,
Acharya P,
Haynes BF
(2024) Cell Host Microbe , 32 , 693 - 709.e7
Grant Support: